Question 1

What is Sekar Kathiresan?

Accepted Answer

Sekar Kathiresan is a Person.

Question 2

How often does Sekar Kathiresan appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 12 articles.

Question 3

When was Sekar Kathiresan first tracked by Ergen?

Accepted Answer

First tracked on May 26, 2026.

Question 4

When was Sekar Kathiresan last mentioned in news?

Accepted Answer

Last active on Jun 07, 2026.

Question 5

What is Sekar Kathiresan's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Sekar Kathiresan in global news coverage?

Accepted Answer

Attention score of 8, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Sekar Kathiresan?

Accepted Answer

VERVE-102 Gene Edit Lowers Cholesterol (May 26, 2026, 12 articles).

Question 8

How did the "VERVE-102 Gene Edit Lowers Cholesterol" event impact Sekar Kathiresan?

Accepted Answer

Sekar Kathiresan>>> is a cardiologist who co-founded Verve PCSK9-inhibitor gene therapy>>> and led the research for VERVE-102. His work is central to the development and success of this gene-editing therapy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.